IMARC Group, a leading market research company, has recently releases report titled “Blood Plasma Derivatives Market Report by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, and Others), End User (Hospitals, Clinics, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global blood plasma derivatives market growth.

How Big Is the Blood Plasma Derivatives Market?

The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Factors Affecting the Growth of the Blood Plasma Derivatives Industry:      

  • Rising Prevalence of Chronic Diseases and Immune Deficiency Disorders:

The increasing incidence of chronic diseases and immune deficiency disorders worldwide is a significant driver for the blood plasma derivatives market. Diseases such as hemophilia, immune deficiencies, and other blood-related conditions require plasma-derived therapies for treatment and management. According to the World Health Organization (WHO), chronic diseases, such as cardiovascular diseases, cancer, and diabetes, are the leading cause of mortality globally. This rising disease burden necessitates the need for plasma derivatives, which are crucial in the development of therapeutics and treatments, thereby driving market growth.

  • Advancements in Plasma Collection and Processing Technologies:

Technological advancements in the collection and processing of plasma have significantly impacted the blood plasma derivatives market. Improved plasma collection techniques, such as plasmapheresis, and enhancements in the purification and manufacturing processes, have increased the safety, efficacy, and availability of plasma-derived products. These advancements not only enhance the quality of plasma derivatives but also expand their therapeutic applications, contributing to market growth. Moreover, innovations in storage and logistics have facilitated the global distribution of plasma products, further driving the market forward.  

  • Growing Awareness and Acceptance of Plasma-Derived Therapies:

There has been a notable increase in awareness and acceptance of plasma-derived therapies among healthcare professionals and patients. This is partly due to educational initiatives by healthcare organizations and plasma product manufacturers, which have highlighted the benefits and safety of plasma-derived therapies. As a result, there is a growing demand for these products for the treatment of various diseases, driving the expansion of the blood plasma derivatives market. The endorsement of plasma-derived therapies by medical practitioners and patient advocacy groups also plays a crucial role in fostering market growth.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample

Leading Companies Operating in the Global Blood Plasma Derivatives Industry:

  • Baxter International Inc.
  • Bayer AG
  • CSL Limited
  • Fusion Health Care Pvt. Ltd.
  • Grifols S.A.
  • Kedrion S.p.A.
  • LFB S.A.
  • Octapharma AG
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Blood Plasma Derivatives Market Report Segmentation:  

By Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Immunoglobulin dominated the largest segment due to its critical role in treating immune deficiencies and autoimmune diseases, driving high demand across various therapeutic areas.

By Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Based on the application, the market has been segmented into hemophilia, hypogammaglobulinemia, immunodeficiency diseases, Von Willebrand’s disease, and others.

By End User:

  • Hospitals
  • Clinics
  • Others

Hospitals are the largest segment as they are primary centers for the diagnosis and treatment of various diseases requiring blood plasma derivatives, ensuring a steady demand.

Regional Insights:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

North America is the largest market due to its advanced healthcare infrastructure, high awareness and adoption of plasma derivative therapies, and strong presence of leading pharmaceutical companies.   

Blood Plasma Derivatives Market Trends:

Government policies and funding initiatives in various countries have been supportive of the blood plasma derivatives market. Regulatory approvals for new plasma products, financial incentives for plasma donation, and investments in healthcare infrastructure contribute to the market's growth.

Governments and health organizations worldwide recognize the importance of plasma-derived therapies in treating a range of diseases and are thus facilitating their development and distribution through supportive legislation and funding. Such policies not only ensure the availability of plasma derivatives but also encourage research and development activities in this sector.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163